Risks related to the handling of antineoplastic agents. Precautions to be observed at rheumatology departments
Euller-Ziegler, L.; Mousnier-Martinez, A.; Michelon, F.; Carmillet, F.; Milletre-Bernardin, M.; Ziegler, G.
Revue du Rhumatisme et des Maladies Osteo-Articulaires 57(2): 123-130
1990
ISSN/ISBN: 0035-2659 PMID: 2181612 Document Number: 357888
Document emailed within 1 workday
Related Documents
Pesce, M. 1999: The handling of antineoplastic agents and Dlgs 626/94. Decreto legislativo (legislative decree) Minerva Medica 90(7-8): 271-278Artico, M. 1974: Chemotherapy of tumors. 3. Chemical review of natural antineoplastic agents: antibiotics and related compounds; enzymes and hormones Il Farmaco; Edizione Scientifica 29(8): 598-646
Tokutome, A.; Taniguchi, R.; Maeda, K.; Saito, Y.; Ishii, T.; Minami, S.; Wano, Y.; Ota, T.; Saitoh, H.; Takeda, K. 2018: The Usefulness of a Pamphlet for Preventing Exposure to Antineoplastic Agents at Cancer Patients' Homes and an Awareness Survey for Pharmacists about Providing Information to Cancer Patients about Exposure to Antineoplastic Agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 833-839
Neiger, R. 1996: Guidelines for the handling of antineoplastic drugs Schweizer Archiv für Tierheilkunde 138(8): 383-386
Ng, L.M.; Jaffe, N. 1970: Possible hazards of handling antineoplastic drugs Pediatrics 46(4): 648-649
Gueguen, G. 1994: Spinal anesthesia in Africa. Risks, precautions Cahiers d'Anesthesiologie 42(5): 651-656
Valanis, B.; Shortridge, L. 1987: Self protective practices of nurses handling antineoplastic drugs Oncology Nursing Forum 14(3): 23-27
Gallelli, J.F. 1982: Evaluating the potential hazard of handling antineoplastic drugs American Journal of Hospital Pharmacy 39(11): 1877
Moore, R.E. 1991: Precautions minimize payment risks with foreign patients Patient Accounts 14(10): 2; 7
Zimmerman, P.F.; Larsen, R.K.; Barkley, E.W.; Gallelli, J.F. 1981: Recommendations for the safe handling of injectable antineoplastic drug products American Journal of Hospital Pharmacy 38(11): 1693-1695
Forestier, F. 1993: Infectious diseases and risks in pregnancy: precautions to take and contra-indications Contraception Fertilite Sexualite 21(11): 827-833
Vignon, G.; Meunier, P.; Jeune, M.; Pansu, D. 1971: Etiological study of 57 hypercalcemia cases observed in a rheumatology clinic Lyon Medical 225(11): 1065-1075
Council, O.The European Communities 1993: Proposal for a council directive amending directive 90/679/EEC on the protection of workers from risks related to exposure to biological agents at work Biotekhnologiya 1993(6): 37
Van Delden, C. 2006: Infectious risks of immunomodulating therapies in rheumatology Revue Medicale Suisse 2(57): 738
Medková, J. 1991: Hygienic examination and follow-up of occupational risks of handling cytostatic drugs at an oncology unit Acta Universitatis Palackianae Olomucensis Facultatis Medicae 129: 241-253
Burhol, P.G. 1986: Reorganization of hospital departments. Should the departments of internal medicine and surgery be replaced by smaller subspecialized departments? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(19-21): 1610-1612
Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A.M.; Diana, P.; Grimaudo, S.; Mingoia, F.; Barraja, P. 1995: Azolophenanthridines as antineoplastic agents Farmaco 50(6): 365-368
Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
1971: Chemistry of antineoplastic agents Minerva Medica 62(28): 1492
Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293